We offer an extensive portfolio of 150+ active pharmaceutical ingredients and intermediates, covering multiple therapeutic areas, with more than 30 years of off-patent API manufacturing experience to our pharmaceutical partners.
Curia Generic APIs
Curia offers an extensive portfolio of 150+ generic APIs, covering multiple therapeutic areas. We offer more than 30 years of generic API manufacturing experience to our pharmaceutical partners.
Products with existing patent protection are intended for development use and Regulatory Purposes only, under 35 U.S.C. 271(e)(1) and article 10.6 of the Directive 2001/EC as amended by the Directive 2004/27/EC.
White Paper
Curia's Patented Process for Intermediates Useful for Upadacitinib
Products with existing patent protection are intended for development use and Regulatory Purposes only, under 35 U.S.C. 271(e)(1) and article 10.6 of the Directive 2001/EC as amended by the Directive 2004/27/EC.
White Paper
Curia's Patented Process for Intermediates Useful for Deucravacitinib
Products with existing patent protection are intended for development use and Regulatory Purposes only, under 35 U.S.C. 271(e)(1) and article 10.6 of the Directive 2001/EC as amended by the Directive 2004/27/EC.
White Paper
Curia's Patented Process for Intermediates Useful for Etrasimod Arginine
Products with existing patent protection are intended for development use and Regulatory Purposes only, under 35 U.S.C. 271(e)(1) and article 10.6 of the Directive 2001/EC as amended by the Directive 2004/27/EC.
